LaSalle St. Investment Advisors LLC Invests $854,000 in Danaher Corporation $DHR

LaSalle St. Investment Advisors LLC acquired a new position in shares of Danaher Corporation (NYSE:DHRFree Report) during the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm acquired 4,484 shares of the conglomerate’s stock, valued at approximately $854,000.

Other hedge funds and other institutional investors also recently made changes to their positions in the company. Meeder Asset Management Inc. acquired a new position in Danaher during the second quarter valued at approximately $44,000. MidFirst Bank bought a new position in shares of Danaher in the 2nd quarter valued at $46,000. Bell Investment Advisors Inc bought a new position in shares of Danaher in the 2nd quarter valued at $47,000. State of Wyoming acquired a new position in shares of Danaher during the 2nd quarter worth $74,000. Finally, Hilton Head Capital Partners LLC acquired a new position in shares of Danaher during the 4th quarter worth $27,000. 79.05% of the stock is currently owned by institutional investors and hedge funds.

Danaher Trading Up 2.2%

DHR opened at $216.14 on Friday. Danaher Corporation has a fifty-two week low of $160.93 and a fifty-two week high of $242.80. The company has a debt-to-equity ratio of 0.48, a current ratio of 1.65 and a quick ratio of 1.25. The company’s 50-day moving average is $195.01 and its 200 day moving average is $192.43. The firm has a market capitalization of $151.94 billion, a PE ratio of 38.39, a P/E/G ratio of 2.63 and a beta of 0.78.

Danaher (NYSE:DHRGet Free Report) last announced its earnings results on Monday, July 20th. The conglomerate reported $1.94 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.85 by $0.09. The company had revenue of $6.26 billion for the quarter, compared to analysts’ expectations of $6.12 billion. Danaher had a return on equity of 11.04% and a net margin of 15.95%.Danaher’s quarterly revenue was up 5.5% on a year-over-year basis. During the same quarter in the previous year, the firm earned $0.77 earnings per share. As a group, research analysts predict that Danaher Corporation will post 8.53 earnings per share for the current fiscal year.

Analysts Set New Price Targets

A number of research firms have recently commented on DHR. HSBC dropped their target price on shares of Danaher from $270.00 to $230.00 and set a “buy” rating for the company in a report on Wednesday, June 3rd. Wall Street Zen lowered Danaher from a “buy” rating to a “hold” rating in a research report on Saturday, April 25th. Stifel Nicolaus decreased their price objective on shares of Danaher from $260.00 to $220.00 and set a “buy” rating for the company in a research report on Wednesday, July 22nd. Evercore reiterated an “outperform” rating and set a $230.00 price target on shares of Danaher in a report on Monday, July 6th. Finally, Wells Fargo & Company lowered their target price on Danaher from $212.00 to $195.00 and set an “equal weight” rating for the company in a report on Wednesday, July 22nd. One analyst has rated the stock with a Strong Buy rating, nineteen have assigned a Buy rating and five have given a Hold rating to the stock. Based on data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and a consensus target price of $228.91.

View Our Latest Report on DHR

About Danaher

(Free Report)

Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.

Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.

See Also

Institutional Ownership by Quarter for Danaher (NYSE:DHR)

Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.